Verdad Advisers, LP

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1812822 BOSTON, MA

Position in SUPN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$325,388

New position

Shares Held

6,295

first reported quarter

Ownership

0.011%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Verdad Advisers, LP holds $1,326,696 across 4 Drug Manufacturers - Specialty & Generic names. SUPN ranks #2 (24.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	32,500	$439,075
2	SUPN	Supernus Pharmaceuticals, Inc. This page	6,295	$325,388
3	ASRT	Assertio Holdings, Inc.	15,541	$296,211
4	BIOA	BioAge Labs, Inc.	15,210	$266,022

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$325,388	6,295	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.